Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

The global impact of the COVID-19 pandemic on health care systems has been significant. The sudden surge in infected cases overwhelmed hospitals and disrupted routine health care services, thus further worsening public health. Managing patients, too, has been challenging due to the variation of COVID-19 symptoms, ranging from mild to severe, that require medical intervention.